379 related articles for article (PubMed ID: 8288963)
1. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
Chang SW
J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
[TBL] [Abstract][Full Text] [Related]
2. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
Sun XM; Hsueh W; Torre-Amione G
Am J Pathol; 1990 Apr; 136(4):949-56. PubMed ID: 2327475
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
4. Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia.
Olszanecki R; Chłopicki S
J Physiol Pharmacol; 1999 Sep; 50(3):443-54. PubMed ID: 10574473
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
Zhang F; Decker K
Eur Cytokine Netw; 1994; 5(3):311-7. PubMed ID: 7948767
[TBL] [Abstract][Full Text] [Related]
6. Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis.
Warren JS; Barton PA; Mandel DM; Matrosic K
Lab Invest; 1990 Dec; 63(6):746-54. PubMed ID: 2255183
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.
Rabinovici R; Bugelski PJ; Esser KM; Hillegass LM; Griswold DE; Vernick J; Feuerstein G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1550-7. PubMed ID: 8263817
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces.
Lee YM; Hybertson BM; Cho HG; Repine JE
J Lab Clin Med; 2002 Nov; 140(5):312-9. PubMed ID: 12434132
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
Heuer HO; Letts G; Meade CJ
J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
Sun XM; Hsueh W
J Immunol; 1991 Jul; 147(2):509-14. PubMed ID: 2071893
[TBL] [Abstract][Full Text] [Related]
12. Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages.
Berdeli A; Akisu M; Dagci T; Akisu C; Yalaz M; Kultursay N
Prostaglandins Leukot Essent Fatty Acids; 2004 Oct; 71(4):227-32. PubMed ID: 15301793
[TBL] [Abstract][Full Text] [Related]
13. Synergism of intratracheally administered tumor necrosis factor with interleukin-1 in the induction of lung edema in rats.
Wesselius LJ; Smirnov IM; O'Brien-Ladner AR; Nelson ME
J Lab Clin Med; 1995 May; 125(5):618-25. PubMed ID: 7738426
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes.
von Asmuth EJ; Buurman WA
J Immunol; 1995 Feb; 154(3):1383-90. PubMed ID: 7529802
[TBL] [Abstract][Full Text] [Related]
15. Primed neutrophils injure rat lung through a platelet-activating factor-dependent mechanism.
Anderson BO; Poggetti RS; Shanley PF; Bensard DD; Pitman JM; Nelson DW; Whitman GJ; Banerjee A; Harken AH
J Surg Res; 1991 May; 50(5):510-4. PubMed ID: 1710005
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cells.
Weber C; Aepfelbacher M; Haag H; Ziegler-Heitbrock HW; Weber PC
Eur J Immunol; 1993 Apr; 23(4):852-9. PubMed ID: 7681399
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rat.
Turner CR; Esser KM; Wheeldon EB; Slivjak M; Smith EF
Circ Shock; 1989 Aug; 28(4):369-84. PubMed ID: 2673572
[TBL] [Abstract][Full Text] [Related]
19. Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats.
Yang J; Li W; Duan M; Zhou Z; Lin N; Wang Z; Sun J; Xu J
Inflamm Res; 2005 Mar; 54(3):133-7. PubMed ID: 15883747
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of tumor metastasis by platelet-activating factor.
Im SY; Ko HM; Kim JW; Lee HK; Ha TY; Lee HB; Oh SJ; Bai S; Chung KC; Lee YB; Kang HS; Chun SB
Cancer Res; 1996 Jun; 56(11):2662-5. PubMed ID: 8653713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
